home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> biomedical companies   |   search    |   registration     |   modification  

registry of biomedical companies

  June 20, 2024
promoting the transfer of scientific know-how between industry and academia
Registry of biomedical companies:

[3] [A] [B] [C] [D] [E] [F] [G] [H] [I] [J] [K] [L] [M] [N] [O] [P] [Q] [R] [S] [T] [U] [V] [W] [X] [Y] [Z] 463 active entries


5 Gabrichevskogo St, Building 8
Moscow, 125367 RUSSIA

Phone: +7 495 780 3417
Fax: +7 495 780 3411

Please notice: This entry hasn't been updated by the submitting company for more than 2 years. It could be possible that this company doesn't longer exists.


As a solution provider ASINEX offers unrivalled chemistry resources, many years of experience in providing discovery chemistry services and an ever expanding range of ADMET screening options. ASINEX's strength lies in the chemistry of small molecules, strongly supported by biology.   

Compound Libraries

ASINEX’s skill in library design derives from its experience as a service provider principally of hit to lead and lead optimization chemistry. In the last few years we have been creating libraries designed to tackle notorious HTS bottlenecks such as novelty, diversity, solubility, lead-likeness and chemical flexibility.  

  1. Historical - 400,000 compounds
  2. Synergy, LeadGen - 35,000 compounds (10,000+ pharmacophores)
  3. High Value -  50,000 compounds (850 in-house templates)
  4. Targeted Libraries – Kinase, GPCR, Protease, Ion Channel
  Chemistry Services 

To date ASINEX has completed more than 400 chemistry projects for 50 customers worldwide. 

Lead Optimization

Custom Synthesis

Exclusive Library Synthesis

High Throughput Chemistry and Purification 


Biological Services: ADMET and DMPK Studies

Selected Categories:
Product Company   Service Company
- Research
- Services

Last update of this entry: June 19, 2008

home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap

Generated by companies 4.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2024 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.